Dr. Peter M. Kally, MD
Ophthalmology (Ophthalmic Plastic and Reconstructive Surgery Physician)
1100 9th Ave, Ms:x10-on
Seattle, WA 98101
Who else practices at this address →
King County includes primary care (5% of residents) and dental (4% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 404
Licensed in Washington since 2022, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmic Plastic and Reconstructive Surgery Physician primary
WA license MD61263154 (first issued 2022; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Virginia Mason Medical Center Seattle, WA
Medical groups
- Virginia Mason Medical Center (867 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 404
- Services billed
- 1,332
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Photography of content of eyes | 350 | 315 |
| Established patient office or other outpatient visit, 30-39 minutes | 161 | 147 |
| New patient office or other outpatient visit, 45-59 minutes | 99 | 99 |
| Established patient office or other outpatient visit, 20-29 minutes | 83 | 68 |
| Exam of visual field with intermediate testing | 63 | 63 |
| Removal of growth of eyelid | 49 | 41 |
| Probing of nasal tear duct | 47 | 43 |
| Established patient office or other outpatient visit, 40-54 minutes | 37 | 37 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 25 | 24 |
| Repair of tendon of upper eyelid | 24 | 24 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Erythromycin (erythromycin base) Other prescribers in Seattle, WA | 107 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Seattle, WA | 39 |
| Neomycin-Polymyxin-Dexameth (neomycin/polymyxin b/dexametha) Other prescribers in Seattle, WA | 36 |
| Ondansetron Hcl Other prescribers in Seattle, WA | 29 |
| Ofloxacin Other prescribers in Seattle, WA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 21 payments worth $6,906 in total to this clinician.
| Amgen Inc. | $6,843 |
|---|---|
| Merz Pharmaceuticals, LLC | $44.97 |
| Baxter Healthcare | $18.06 |
| Compensation for services other than consulting (speaking, faculty) | $6,163 |
|---|---|
| Food and Beverage | $711 |
| Travel and Lodging | $32.20 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $2,550 |
| Amgen Inc. Apr 28, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $2,550 |
| Amgen Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $1,063 |
| Amgen Inc. Nov 21, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to Everett, WA | $32.20 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.